These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16814664)

  • 21. Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction.
    Stein A; Knödler M; Makowski M; Kühnel S; Nekolla S; Keithahn A; Weidl E; Groha P; Schürmann M; Saraste A; Botnar R; Oostendorp RA; Ott I
    BMC Cardiovasc Disord; 2010 Sep; 10():43. PubMed ID: 20849606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Erythropoietin enhances the therapy potency of autologous bone marrow stromal cells in a rat heart infarction model via phosphatidylinositol-3-kinase/Akt pathway].
    Zhang DG; Zhang FM; Zhang YQ; Zhou F; Gao X; Li CF; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):912-6. PubMed ID: 17217721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
    Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
    Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.
    Lipsic E; van der Meer P; Voors AA; Westenbrink BD; van den Heuvel AF; de Boer HC; van Zonneveld AJ; Schoemaker RG; van Gilst WH; Zijlstra F; van Veldhuisen DJ
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):135-41. PubMed ID: 16761193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction.
    Angeli FS; Amabile N; Shapiro M; Mirsky R; Bartlett L; Zhang Y; Virmani R; Chatterjee K; Boyle A; Grossman W; Yeghiazarians Y
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):409-20. PubMed ID: 20809214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction.
    Kanashiro-Takeuchi RM; Takeuchi LM; Hatzistergos K; Quevedo H; Selem SM; Treuer AV; Premer C; Balkan W; Margitich I; Song Y; Hu Q; Hare JM
    Clin Transl Sci; 2011 Jun; 4(3):168-74. PubMed ID: 21707946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.
    Kobayashi H; Minatoguchi S; Yasuda S; Bao N; Kawamura I; Iwasa M; Yamaki T; Sumi S; Misao Y; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Tabata Y; Fujiwara H
    Cardiovasc Res; 2008 Sep; 79(4):611-20. PubMed ID: 18541523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.
    Heeschen C; Aicher A; Lehmann R; Fichtlscherer S; Vasa M; Urbich C; Mildner-Rihm C; Martin H; Zeiher AM; Dimmeler S
    Blood; 2003 Aug; 102(4):1340-6. PubMed ID: 12702503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart.
    Klopsch C; Skorska A; Ludwig M; Lemcke H; Maass G; Gaebel R; Beyer M; Lux C; Toelk A; Müller K; Maschmeier C; Rohde S; Mela P; Müller-Hilke B; Jockenhoevel S; Vollmar B; Jaster R; David R; Steinhoff G
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29752300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Migration of bone marrow-derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarction.
    Brunner S; Huber BC; Weinberger T; Vallaster M; Wollenweber T; Gerbitz A; Hacker M; Franz WM
    J Cell Mol Med; 2012 Jan; 16(1):152-9. PubMed ID: 21362129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model.
    Schuh A; Liehn EA; Sasse A; Hristov M; Sobota R; Kelm M; Merx MW; Weber C
    Basic Res Cardiol; 2008 Jan; 103(1):69-77. PubMed ID: 17999028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct implantations of erythropoietin and autologous EPCs in critical limb ischemia (CLI) area restored CLI area blood flow and rescued remote AMI-induced LV dysfunction.
    Lee FY; Luo CW; Wallace CG; Chen KH; Sheu JJ; Yin TC; Chai HT; Yip HK
    Biomed Pharmacother; 2019 Oct; 118():109296. PubMed ID: 31545254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells.
    Kang J; Yun JY; Hur J; Kang JA; Choi JI; Ko SB; Lee J; Kim JY; Hwang IC; Park YB; Kim HS
    Cardiovasc Res; 2014 Oct; 104(1):171-82. PubMed ID: 25082847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Speckle tracking imaging improves in vivo assessment of EPO-induced myocardial salvage early after ischemia-reperfusion in rats.
    Treguer F; Donal E; Tamareille S; Ghaboura N; Derumeaux G; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1679-86. PubMed ID: 20363897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
    Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.
    Ahmet I; Tae HJ; Brines M; Cerami A; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2013 Jun; 345(3):446-56. PubMed ID: 23584743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of rHu-EPO on myocyte apoptosis and cardiac function following acute myocardial infarction in rats.
    Ye L; Du X; Xia J; Ping J
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):55-8. PubMed ID: 15934309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naoxintong inhibits myocardial infarction injury by VEGF/eNOS signaling-mediated neovascularization.
    Wang H; Qiu L; Ma Y; Zhang L; Chen L; Li C; Geng X; You X; Gao X
    J Ethnopharmacol; 2017 Sep; 209():13-23. PubMed ID: 28669772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenomedullin enhances therapeutic potency of bone marrow transplantation for myocardial infarction in rats.
    Fujii T; Nagaya N; Iwase T; Murakami S; Miyahara Y; Nishigami K; Ishibashi-Ueda H; Shirai M; Itoh T; Ishino K; Sano S; Kangawa K; Mori H
    Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1444-50. PubMed ID: 15539427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.